These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29381230)

  • 21. Clinical and behavioural features of SYNGAP1-related intellectual disability: a parent and caregiver description.
    Wright D; Kenny A; Eley S; McKechanie AG; Stanfield AC
    J Neurodev Disord; 2022 Jun; 14(1):34. PubMed ID: 35655128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene.
    Wang Y; Lv Y; Yang X; Li Y; Li Z; Gao Z; Gai Z; Liu Y
    Stem Cell Res; 2022 Oct; 64():102922. PubMed ID: 36183676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chewing induced reflex seizures ("eating epilepsy") and eye closure sensitivity as a common feature in pediatric patients with SYNGAP1 mutations: Review of literature and report of 8 cases.
    von Stülpnagel C; Hartlieb T; Borggräfe I; Coppola A; Gennaro E; Eschermann K; Kiwull L; Kluger F; Krois I; Møller RS; Rössler F; Santulli L; Schwermer C; Wallacher-Scholz B; Zara F; Wolf P; Kluger G
    Seizure; 2019 Feb; 65():131-137. PubMed ID: 30685520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation.
    Hamdan FF; Gauthier J; Spiegelman D; Noreau A; Yang Y; Pellerin S; Dobrzeniecka S; Côté M; Perreau-Linck E; Carmant L; D'Anjou G; Fombonne E; Addington AM; Rapoport JL; Delisi LE; Krebs MO; Mouaffak F; Joober R; Mottron L; Drapeau P; Marineau C; Lafrenière RG; Lacaille JC; Rouleau GA; Michaud JL;
    N Engl J Med; 2009 Feb; 360(6):599-605. PubMed ID: 19196676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Behavioral Profile of SYNGAP1-Related Intellectual Disability.
    Wright D; Kenny A; Mizen LAM; McKechanie AG; Stanfield AC
    Am J Intellect Dev Disabil; 2024 May; 129(3):199-214. PubMed ID: 38657965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.
    Weldon M; Kilinc M; Lloyd Holder J; Rumbaugh G
    J Neurodev Disord; 2018 Feb; 10(1):6. PubMed ID: 29402231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome.
    Carlston CM; Bleyl SB; Andrews A; Meyers L; Brown S; Bayrak-Toydemir P; Bale JF; Botto LD
    Am J Med Genet A; 2019 May; 179(5):792-796. PubMed ID: 30773818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive behavioral analysis of heterozygous Syngap1 knockout mice.
    Nakajima R; Takao K; Hattori S; Shoji H; Komiyama NH; Grant SGN; Miyakawa T
    Neuropsychopharmacol Rep; 2019 Sep; 39(3):223-237. PubMed ID: 31323176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-parametric analysis of 57 SYNGAP1 variants reveal impacts on GTPase signaling, localization, and protein stability.
    Meili F; Wei WJ; Sin WC; Meyers WM; Dascalu I; Callaghan DB; Rogic S; Pavlidis P; Haas K
    Am J Hum Genet; 2021 Jan; 108(1):148-162. PubMed ID: 33308442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the phenotype of a recurrent de novo variant in PACS1 causing intellectual disability.
    Gadzicki D; Döcker D; Schubach M; Menzel M; Schmorl B; Stellmer F; Biskup S; Bartholdi D
    Clin Genet; 2015 Sep; 88(3):300-2. PubMed ID: 25522177
    [No Abstract]   [Full Text] [Related]  

  • 31. Upregulation of SYNGAP1 expression in mice and human neurons by redirecting alternative splicing.
    Yang R; Feng X; Arias-Cavieres A; Mitchell RM; Polo A; Hu K; Zhong R; Qi C; Zhang RS; Westneat N; Portillo CA; Nobrega MA; Hansel C; Garcia Iii AJ; Zhang X
    Neuron; 2023 May; 111(10):1637-1650.e5. PubMed ID: 36917980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel HIST1HE pathogenic variant in a girl with macrocephaly and intellectual disability: a new case and review of literature.
    Pelle A; Pezzoli L; Apuril E; Iascone M; Selicorni A
    Clin Dysmorphol; 2021 Jan; 30(1):39-43. PubMed ID: 33086257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterozygous nonsense variant of CHD8 in a patient with forme-fruste Marfan syndrome and intellectual disability.
    Yamada M; Yamaguchi Y; Uehara T; Yagihashi T; Kosaki K
    Congenit Anom (Kyoto); 2021 Jan; 61(1):30-32. PubMed ID: 32951261
    [No Abstract]   [Full Text] [Related]  

  • 34. [Autosomal dominant mental retardation type 5 caused by
    Wang XL; Tian YN; Chen C; Peng J
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):489-496. PubMed ID: 37272175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineating the Smith-Kingsmore syndrome phenotype: Investigation of 16 patients with the MTOR c.5395G > A p.(Glu1799Lys) missense variant.
    Poole RL; Curry PDK; Marcinkute R; Brewer C; Coman D; Hobson E; Johnson D; Lynch SA; Saggar A; Searle C; Scurr I; Turnpenny PD; Vasudevan P; Tatton-Brown K
    Am J Med Genet A; 2021 Aug; 185(8):2445-2454. PubMed ID: 34032352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.
    Jimenez-Gomez A; Niu S; Andujar-Perez F; McQuade EA; Balasa A; Huss D; Coorg R; Quach M; Vinson S; Risen S; Holder JL
    J Neurodev Disord; 2019 Aug; 11(1):18. PubMed ID: 31395010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual social attention in SYNGAP1-related intellectual disability.
    Wright D; Kenny A; Eley S; McKechanie AG; Stanfield AC
    Autism Res; 2024 Jun; 17(6):1083-1093. PubMed ID: 38698724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaufman oculocerebrofacial syndrome in sisters with novel compound heterozygous mutation in UBE3B.
    Pedurupillay CR; Barøy T; Holmgren A; Blomhoff A; Vigeland MD; Sheng Y; Frengen E; Strømme P; Misceo D
    Am J Med Genet A; 2015 Mar; 167A(3):657-63. PubMed ID: 25691420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternally inherited MAF variant associated with variable expression of Aymé-Gripp syndrome.
    Alkhunaizi E; Koenekoop RK; Saint-Martin C; Russell L
    Am J Med Genet A; 2019 Nov; 179(11):2233-2236. PubMed ID: 31390148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.